Circulating LR11 is a novel soluble-receptor marker for early-stage clinical conditions in patients with non-Hodgkin's lymphoma
Keywords: NHL; non-Hodgkin's lymphoma; sLR11; soluble LDL receptor relative with 11 ligand-binding repeats; suPAR; soluble urokinase-type plasminogen activator receptor; sIL-2R; soluble interleukin-2 receptor; FL; follicular lymphoma; DLBCL; diffuse large B-cell ly